50 mg of semaglutide Oral taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial approved exercise Weight Loss Medication - IdentID

Not product data

Regular follow-up appointments will provide opportunities to assess your progress, celebrate your achievements, and address any challenges that arise

A good candidate for semaglutide is an adult who meets the following criteria: They have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol

Much like any surgery has its risks, these medications also have theirs, notes Dr

Continue and reassess quarterly

Brand-name GLP-1s such as Ozempic, Wegovy, or Mounjaro cost more, up to $1,549 per month